An Overview of NIDA's Medications Pipeline for the Treatment of Opioid Use Disorder

Presented By: Marta De Santis, PhD

Speaker Biography: Dr. Marta De Santis is a Regulatory Affairs Specialist at the Division of Therapeutics and Medical Consequences at the National Institute on Drug Abuse (NIDA), National Institutes of Health (NIH). She graduated from the National University of Córdoba, Argentina with a Master’s degree in Biochemistry and a Doctorate in Biochemical Sciences. She pursued postdoctoral studies at the NIH and later worked as a regulatory affairs scientist at Technical Resources International. Dr De Santis joined the Regulatory Affairs Branch of the division 15 years ago and since then has provided professional expertise for the successful completion of clinical studies according to all applicable U.S. regulatory requirements. She currently manages the Division’s medications pipeline for the treatment of opioid use disorder (OUD) and is closely involved in identifying barriers to medication development in the field of substance use disorders.

Webinar: An Overview of NIDA's Medications Pipeline for the Treatment of Opioid Use Disorder

Webinar Abstract: An overview of NIDA’s current medications pipeline for the treatment of opioid use disorder (OUD) is presented. OUD and its consequences are a major public health concern with a devastating opioid use and overdose crisis in the US. Misuse and abuse of prescription opioids (including fentanyl), heroin and others are associated with a high burden of morbidity and mortality. It has been reported that around 50 million adults suffered from chronic pain in 2019. Opioids that are often prescribed for their treatment can lead to opioid misuse and OUD. Approximately 2.4 million Americans have OUD and many started their addiction with prescribed opioids. One of the most devastating consequences of opioid misuse is opioid overdose, which can produce respiratory depression and death. Drug overdose is the leading cause of accidental death in the US, with an estimation of 70,630 deaths in 2019; 49,860 of those being overdose deaths related to opioids. Medication-assisted treatment is a recommended treatment for individuals with OUD.

Earn PACE Credits:
1. Make sure you’re a registered member of LabRoots https://www.labroots.com/virtual-event/opioid-crisis-2021/agenda
2. Watch the webinar on YouTube or on the LabRoots Website https://www.labroots.com/webinar/overview-nida-s-medications-pipeline-treatment-opioid-disorder
3. Click Here to get your PACE credits (Expiration date – November 03, 2023): https://www.labroots.com/credit/pace-credits/6889/third-party

LabRoots on Social:
Facebook: https://www.facebook.com/LabRootsInc
Twitter: https://twitter.com/LabRoots
LinkedIn: https://www.linkedin.com/company/labroots
Instagram: https://www.instagram.com/labrootsinc
Pinterest: https://www.pinterest.com/labroots/
SnapChat: labroots_inc